HERON THERAPEUTICS (UK) Valuation

What is the enterprise value of HERON THERAPEUTICS? Calculating the true value of any business is not as easy as it may seem. While the market cap of a public entity, such as HERON THERAPEUTICS, is its stock price multiplied by the total number of shares outstanding, calculating HERON THERAPEUTICS's enterprise value requires a different approach. It uses HERON THERAPEUTICS's balance sheet items such as long-term debt, the book value of the preferred stock, minority interest, and other important financials.
HERON THERAPEUTICS INC regular Real Value cannot be determined due to lack of data. The prevalent price of HERON THERAPEUTICS INC is $0.0. Based on Macroaxis valuation methodology, the firm cannot be evaluated at this time. Our model calculates the value of HERON THERAPEUTICS INC from examining the firm fundamentals such as return on equity of (96.72) %, and Return On Asset of (33.85) % as well as analyzing its technical indicators and Probability Of Bankruptcy. In general, we encourage acquiring undervalued assets and dropping overvalued assets since, in the future, asset prices and their ongoing real values will come together.
  
HERON THERAPEUTICS Valuation Module provides a unique way to ballpark how much the company is worth today. It is done using both, our quantitative analysis of the company fundamentals as well as its intrinsic market price estimation to project the real value. We also take into consideration other essential factors such as HERON THERAPEUTICS's management style, its c-level domain expertise and tenure, its overall leadership history as well as current capital structure, and future earnings potential.

HERON THERAPEUTICS Valuation Ratios as Compared to Competition

Comparative valuation techniques use various fundamental indicators to help in determining HERON THERAPEUTICS's current stock value. Our valuation model uses many indicators to compare HERON THERAPEUTICS value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across HERON THERAPEUTICS competition to find correlations between indicators driving HERON THERAPEUTICS's intrinsic value. More Info.
HERON THERAPEUTICS INC is number one stock in price to sales category among related companies. It is number one stock in price to book category among related companies fabricating about  0.49  of Price to Book per Price to Sales. The ratio of Price to Sales to Price to Book for HERON THERAPEUTICS INC is roughly  2.06 . Comparative valuation analysis is a catch-all model that can be used if you cannot value HERON THERAPEUTICS by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for HERON THERAPEUTICS's Stock . Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the HERON THERAPEUTICS's earnings, one of the primary drivers of an investment's value.
Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates HERON THERAPEUTICS's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in HERON THERAPEUTICS and how it compares across the competition.
Check out Trending Equities. Note that the HERON THERAPEUTICS INC information on this page should be used as a complementary analysis to other HERON THERAPEUTICS's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Other Tools for HERON Stock

When running HERON THERAPEUTICS INC price analysis, check to measure HERON THERAPEUTICS's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy HERON THERAPEUTICS is operating at the current time. Most of HERON THERAPEUTICS's value examination focuses on studying past and present price action to predict the probability of HERON THERAPEUTICS's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move HERON THERAPEUTICS's price. Additionally, you may evaluate how the addition of HERON THERAPEUTICS to your portfolios can decrease your overall portfolio volatility.
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Go
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Go
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Go
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Go
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Go
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Equity Valuation
Check real value of public entities based on technical and fundamental data
Go
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Go
Watchlist Optimization
Optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm
Go
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Go